Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer

被引:0
|
作者
Capuozzo, Maurizio [1 ]
Santorsola, Mariachiara [2 ]
Ianniello, Monica [3 ]
Ferrara, Francesco [1 ]
Zovi, Andrea [4 ]
Petrillo, Nadia [3 ]
Castiello, Rosa [3 ]
Fantuz, Maria Rosaria [3 ]
Ottaiano, Alessandro [2 ]
Savarese, Giovanni [3 ]
机构
[1] ASL Naples 3, Coordinamento Farmaceut, I-80056 Ercolano, Italy
[2] IRCCS G Pascale, Ist Nazl Tumori Napoli, Via M Semmola, I-80131 Naples, Italy
[3] Ctr Polidiagnost Strumentale Srl, AMES, Via Padre Carmine Fico 24, I-80013 Casalnuovo Di Napoli, Italy
[4] Minist Hlth, Viale Giorgio Ribotta 5, I-00144 Rome, Italy
关键词
prostate cancer; androgen-deprivation therapy; immunotherapy; PARP inhibitors; precision medicine; PHASE-III TRIAL; SIPULEUCEL-T; DOUBLE-BLIND; PLUS STANDARD; OPEN-LABEL; CASTRATION; IPILIMUMAB; IMMUNOTHERAPY; ENZALUTAMIDE; MULTICENTER;
D O I
10.3390/diseases12050087
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Prostate cancer, a prevalent malignancy affecting the prostate gland, is a significant global health concern. Androgen-deprivation therapy (ADT) has proven effective in controlling advanced disease, with over 50% of patients surviving at the 10-year mark. However, a diverse spectrum of responses exists, and resistance to ADT may emerge over time. This underscores the need to explore innovative treatment strategies for effectively managing prostate cancer progression. Ongoing research endeavors persist in unraveling the complexity of prostate cancer and fostering the development of biologic and innovative approaches, including immunotherapies and targeted therapies. This review aims to provide a valuable synthesis of the dynamic landscape of emerging drug modalities in this context. Interestingly, the complexities posed by prostate cancer not only present a formidable challenge but also serve as a model and an opportunity for translational research and innovative therapies in the field of oncology.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] Modalities for Imaging of Prostate Cancer
    Hou, A. H.
    Swanson, D.
    Barqawi, A. B.
    ADVANCES IN UROLOGY, 2009, 2009
  • [42] Imaging modalities for prostate cancer
    Futterer, Jurgen J.
    Barentsz, J. O.
    Heijmijnk, Stijn T. W. P. J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 923 - 937
  • [43] Drug-Drug Interactions in Prostate Cancer Treatment
    Hebenstreit, Doris
    Pichler, Renate
    Heidegger, Isabel
    CLINICAL GENITOURINARY CANCER, 2020, 18 (02) : E71 - E82
  • [44] Overcoming Drug Resistance and Treating Advanced Prostate Cancer
    Semenas, Julius
    Allegrucci, Cinzia
    Boorjian, Stephen A.
    Mongan, Nigel P.
    Persson, Jenny Liao
    CURRENT DRUG TARGETS, 2012, 13 (10) : 1308 - 1323
  • [45] PROTACs as Therapeutic Modalities for Drug Discovery in Castration-Resistant Prostate Cancer
    Wang, Ling-Yu
    Hung, Chiu-Lien
    Wang, Tsan-Chun
    Hsu, Hung-Chih
    Kung, Hsing-Jien
    Lin, Kwang-Huei
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2025, 65 : 375 - 396
  • [46] Advanced Treatment Modalities for Vitiligo
    Patel, Nishit S.
    Paghdal, Kapila V.
    Cohen, George F.
    DERMATOLOGIC SURGERY, 2012, 38 (03) : 381 - 391
  • [47] Innovative approaches to the treatment of advanced breast cancer - Introduction
    Norton, L
    Piccart, MJ
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 1 - 2
  • [48] Treatment strategies for locally advanced prostate cancer
    Zhang Kai
    Zhang Xianghua
    中华医学杂志(英文版), 2014, 127 (05) : 952 - 955
  • [49] Optimal treatment of locally advanced prostate cancer
    Manfred P. Wirth
    Oliver W. Hakenberg
    Michael Froehner
    World Journal of Urology, 2007, 25 : 169 - 176
  • [50] Current perspectives in the treatment of advanced prostate cancer
    Victor Valdespino
    Panagiotis Tsagozis
    Pavel Pisa
    Medical Oncology, 2007, 24 : 273 - 286